InnoPharmax
About
About Us
Organization
Our History
News
News
R&D
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Products
GemOral
N11005
Technologies
OralPAS®
OralPAS Pro®
MUCR™
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Core Products
GemOral
N11005
N11005
>
Core Products
>
home
N11005
Overview of N11005 Prandial Oral Insulin
Current oral insulin developments are focused on basal insulin, N11005 has the potential to be the first prandial oral insulin, it offers several advantages for overall glycemic control.
N11005 Mimics Natural Insulin Action Profile
Natural Insulin Secretion Pathway
Injected Insulin Pathway in Diabetic Patients
N11005 Mimics Natural Insulin Secretion Pathway
uGear Design
-
Website Info.